Dongmei Zhao

39PUBLICATIONS
13CO-AUTHORS
AllergyPredictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Nov 03, 2026
Design, synthesis, and antifungal activity of (phenylethynyl) phenoxymethyl-1,3-dioxolane triazoles as novel CYP51 inhibitors.

|Oct 23, 2026
CYP1B1 Enzymatic Activity Promotes Non-Small Cell Lung Cancer Metastasis: Antimetastatic Effects of Novel CYP1B1 Inhibitors.

|Oct 23, 2026
Design, Synthesis, and Biological Evaluation of Novel Tetrazole-Containing Tetrahydroisoquinoline Derivatives as Putative CYP51 Inhibitors against Candida Species.

|Aug 27, 2026
Design, Synthesis, Biological Activity Evaluation, and Molecular Docking of 2-Aminopyrimidine-Based PKMYT1 Inhibitors.

|Aug 27, 2026
Design, Synthesis, and Biological Activity Evaluation of Quinazoline-Based PLK4 Inhibitors.

|Jul 16, 2026
Discovery of ZSL-M028: A Potent, Selective and Orally Available Quinazoline-Based PLK4 Inhibitor Targeting TRIM37-Amplified Neuroblastoma.

Pageof 7

Frequent Collaborators

12 joint publications

Maosheng Cheng

7 joint publications

Nian Liu

3 joint publications

Hanxun Wang

2 joint publications

Yongxiang Liu